Antoon M. Van Doornmalen
Oss, NB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0.
Journal: Frontiers in immunology
Published: September 23, 2020
Pharmacological validation of TDO as a target for Parkinson's disease.
Journal: The FEBS journal
Published: September 11, 2020
Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites.
Journal: Oncotarget
Published: April 08, 2020
Cell Panel Profiling Reveals Conserved Therapeutic Clusters and Differentiates the Mechanism of Action of Different PI3K/mTOR, Aurora Kinase and EZH2 Inhibitors.
Journal: Molecular cancer therapeutics
Published: June 22, 2016
Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 26, 2015
Selective Targeting of CTNBB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs.
Journal: PloS one
Published: December 07, 2014
High-throughput fluorescence-based screening assays for tryptophan-catabolizing enzymes.
Journal: Journal of biomolecular screening
Published: May 30, 2014
Comparison of the cancer gene targeting and biochemical selectivities of all targeted kinase inhibitors approved for clinical use.
Journal: PloS one
Published: December 19, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026